Literature DB >> 20171565

Is a fixed value for the least significant change appropriate?

Lisa Nelson1, Karen Y Gulenchyn1, Mark Atthey1, Colin E Webber2.   

Abstract

The least significant change (LSC) represents the smallest difference between successive measurements of bone mineral density (BMD) that can be considered to be a real change and not attributable to chance. The LSC is derived from same-day in vivo BMD precision measurements. Our first objective was to determine if the LSC differs between technologists. Our second objective was to determine if patient body size influenced the LSC. Each of 8 technologists measured same-day precision in groups of 30 patients for the lumbar spine and the total trochanter and neck regions of the proximal femur. At the spine, precision ranged from 0.008 to 0.011g/cm(2) and did not differ between technologists. Precision for the total region of the left proximal femur ranged from 0.006 to 0.016g/cm(2) and did differ between technologists. For the trochanter and neck regions, precision ranged from 0.008 to 0.013g/cm(2) for the former and from 0.010 to 0.020g/cm(2) for the latter, again, with inter-technologist differences. The LSC for the lumbar spine increased linearly from 0.022 to 0.031g/cm(2) when body mass index (BMI) increased from 19.5 to 31.3kg/m(2). In contrast, there was no discernable impact of BMI on the LSC for any of the proximal femur regions. The LSC at the spine is determined by the patient, whereas the LSC at the femur is determined by the technologist. Use of a single value for the LSC will lead to misinterpretations of the significance of BMD changes at both the spine and the proximal femur. Copyright (c) 2010 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171565     DOI: 10.1016/j.jocd.2009.10.001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  7 in total

1.  Changes in bone mineral density in women following 1-year gastric bypass surgery, published by Casagrande DS et al.--reply.

Authors:  Daniela Schaan Casagrande; Rodolfo Schneider; Beatriz D Schaan
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA.

Authors:  Masayuki Takakuwa; Jun Iwamoto; Koichi Itabashi
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

3.  Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT.

Authors:  Elaine W Yu; Bijoy J Thomas; J Keenan Brown; Joel S Finkelstein
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

4.  Bone loss after bariatric surgery: discordant results between DXA and QCT bone density.

Authors:  Elaine W Yu; Mary L Bouxsein; Adam E Roy; Chantel Baldwin; Abby Cange; Robert M Neer; Lee M Kaplan; Joel S Finkelstein
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

5.  Upright activity and higher motor function may preserve bone mineral density within 6 months of stroke: a longitudinal study.

Authors:  Karen Borschmann; Sandra Iuliano; Ali Ghasem-Zadeh; Leonid Churilov; Marco Y C Pang; Julie Bernhardt
Journal:  Arch Osteoporos       Date:  2018-01-08       Impact factor: 2.617

6.  Lipid is heterogeneously distributed in muscle and associates with low radiodensity in cancer patients.

Authors:  Amritpal S Bhullar; Ana Anoveros-Barrera; Abha Dunichand-Hoedl; Karen Martins; David Bigam; Rachel G Khadaroo; Todd McMullen; Oliver F Bathe; Charles T Putman; Michael T Clandinin; Vickie E Baracos; Vera C Mazurak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-27       Impact factor: 12.910

7.  Age, Sex, and Race/Ethnicity Associations between Fat Mass and Lean Mass with Bone Mineral Density: NHANES Data.

Authors:  Meghan E Garvey; Ling Shi; Philimon N Gona; Philip J Troped; Sarah M Camhi
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.